Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma

Status Completed

Clinical Trial Summary

The investigators propose to evaluate a novel diagnostic approach for Kaposi's sarcoma (KS) that may be eventually deployed with portable, point-of-care techniques. This approach features confocal microscopy. The investigators will compare this new approach with the gold standard of histology from a traditional skin punch biopsy (which is standard of care) to determine the sensitivity and specificity of portable confocal microscopy in diagnosing KS.

Clinical Trial Description

The investigators will perform a cross-sectional study of 500 patients in routine clinical care settings who are suspected to have KS on clinical grounds and for whom skin punch biopsy and histopathological examination is indicated as part of standard of care. Patients will be evaluated with both the gold standard for diagnosis of KS (skin punch biopsy followed by histopathology) and portable confocal microscopy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03050788
Study type	Interventional
Source	Massachusetts General Hospital
Contact
Status	Completed
Phase	N/A
Start date	March 10, 2017
Completion date	February 28, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06445166` - Propranolol for the Treatment of Kaposi Sarcoma in Adults	Phase 2
Recruiting	`NCT04941274` - Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma	Phase 1/Phase 2
Completed	`NCT03160183` - Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
Recruiting	`NCT03993106` - A Study of sEphB4-HSA in Kaposi Sarcoma	Phase 2
Recruiting	`NCT05081141` - HHV8 and Solid Organ Transplantation
Completed	`NCT00395278` - Development of Serologic Assays for Human Herpes Virus-8
Recruiting	`NCT02408861` - Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	Phase 1
Completed	`NCT03296553` - Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.	Phase 2
Recruiting	`NCT04305691` - Trial of Ixazomib for Kaposi Sarcoma	Phase 2
Completed	`NCT03316274` - Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma	Early Phase 1
Recruiting	`NCT05859074` - A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer	Phase 1
Terminated	`NCT04893018` - NT-I7 for Kaposi Sarcoma in Patients With or Without HIV	Phase 1
Recruiting	`NCT06375122` - Natural History Study of Kaposi Sarcoma
Recruiting	`NCT05663502` - Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Recruiting	`NCT05329792` - L19IL2/L19TNF in Skin Cancer Patients	Phase 2
Not yet recruiting	`NCT05411237` - Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma	Phase 3
Completed	`NCT03404297` - Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya	N/A
Terminated	`NCT01412515` - A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma	Phase 2
Not yet recruiting	`NCT06004011` - AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)	N/A
Terminated	`NCT02080416` - Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors	Phase 0